EP2101594A1 - Composition lipidique présentant des propriétés d'intérêt - Google Patents
Composition lipidique présentant des propriétés d'intérêtInfo
- Publication number
- EP2101594A1 EP2101594A1 EP07870279A EP07870279A EP2101594A1 EP 2101594 A1 EP2101594 A1 EP 2101594A1 EP 07870279 A EP07870279 A EP 07870279A EP 07870279 A EP07870279 A EP 07870279A EP 2101594 A1 EP2101594 A1 EP 2101594A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- oil
- lipid composition
- fatty acid
- weight
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/60—Salad dressings; Mayonnaise; Ketchup
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a lipid composition having both nutritional and organoleptic properties of interest.
- the invention also relates to food compositions containing said lipid composition.
- the ISIO4 oil developed and marketed by the applicant, contains 10% saturated fatty acids, 60% monounsaturated fatty acids, mainly oleic acid ( ⁇ 9), and 30% polyunsaturated fatty acids, of which 28 , 1% linoleic acid ( ⁇ 6) and 1.9% alpha-linolenic acid ( ⁇ 3), with a ratio ⁇ 6 / ⁇ 3 close to 15.
- composition subject of the patent application FR 2 878 413 developed and marketed by the applicant under the trade names ISIO Protect and ISIO4 Olive, contains 10% saturated fatty acids, 57% monounsaturated fatty acids and 33% of polyunsaturated fatty acids, comprising 27.5% of linoleic acid (co6) and 5.5% of alpha-linolenic acid ( ⁇ 3), in a ratio ⁇ 6 / ⁇ 3 of 5 more in line with current nutritionists' recommendations for whole lipids of the daily diet.
- said lipid composition can be described as "balanced".
- DHA docosahexaenoic acid
- the omega 3 alpha-linolenic acid superior derivative for its physiological properties in the areas of brain development [Uauy R. et al. 2001 Lipids 36 (9): 885-895 - Heird WC et al. 2005 Ann Rev Nutr 25: J49-571], cognition, vision [SanGiovanni JP et al. 2005 Prog Retin Eye Res 24 (1): 87-
- DHA is indeed the major constituent fatty acid of the neurons and retinal rod-shaped membranes and is active in the mechanisms of neurotransmission [Vancassel S. et al. 2004 OCL 11 (1): 58-65 - Chalon S. et al. 2006
- the alpha-linolenic acid contents are less than 4% with a ratio of "omega 6 fatty acids / omega 3 fatty acids" greater than 4.5.
- Such lipid compositions are therefore not sufficiently balancing in terms of alpha-linolenic acid intake of the omega 3 family.
- the patent in question does not give any details on the preservation of the organoleptic properties of such compositions during the course of the time.
- patent EP 0494707 claims salad oil compositions comprising at least 2% of olive oil and at least 10% of unrefined vegetable oils.
- the exemplary embodiments contain between 5% and 20% of olive oil and between 30% and 95% of unrefined vegetable oils, that is to say not more than 50% of refined vegetable oils in the final mix.
- compositions also have unbalanced linoleic / alpha-linolenic ratios greater than 12, less than 4% alpha-linolenic acid of the omega 3 family and more than 40% of polyunsaturated fatty acids which create an environment that is too rich in omega 6 if the composition must contain higher fatty acids of the omega 3 family such as docosahexaenoic acid (DHA).
- DHA docosahexaenoic acid
- mixtures of refined oils containing significant amounts of alpha-linolenic acid provided by including rapeseed oil (Canola), soybean, walnut, camelina, flax, perilla, inca inchi, kiwifruit seeds or their mixtures can quickly lose their neutrality of taste during their aging under the action of light, combined with that of air and temperature.
- rapeseed oil Canola
- soybean soybean
- walnut camelina
- flax flax
- perilla inca inchi
- the lipidic ingredients rich in higher derivatives of the ⁇ 3 series such as DHA (fatty acid containing six unsaturations)
- DHA fatty acid containing six unsaturations
- the lipidic ingredients rich in docosahexaenoic acid (DHA) and low eicosapentaenoic acid (EPA), whether marine or microalgal, are particularly fragile both organoleptically and oxidatively, when they contain more 25% by weight of DHA.
- DHA docosahexaenoic acid
- EPA eicosapentaenoic acid
- lipid composition To prepare such a lipid composition, it is therefore necessary to sufficiently mask the sui-generis taste of ingredients rich in DHA, whether they come from fish lipids or marine microalgae, to sufficiently mask the taste of alteration of the ingredients rich in DHA during the aging of the composition, to sufficiently mask the taste of alteration of rapeseed oil (or other oil rich in alpha-linolenic acid) during this aging, and to protect the lipid composition of the effect harmful to the various radiations of light, the action of light being known as a determining factor in the development of autoxidation reactions of unsaturated lipids, particularly those rich in polyunsaturated polyunsaturated fatty acids of 3 or more, as particularly the alpha-linolenic and docosahexaenoic fatty acids of the omega 3 family.
- the present invention aims to provide a novel lipid composition having satisfactory organoleptic and nutritional properties, said lipid composition more specifically meeting the nutritional needs of consumers for whom it is intended.
- the object of the present invention is to provide a novel balancing lipid composition which compensates for the insufficiency of the ⁇ 3 intake of the daily diet and adapted to persons in need of a DHA supplement via their current diet.
- the object of the present invention is to provide a new lipid composition containing, in particular, rapeseed oil and lipid ingredients rich in DHA, which is organoleptically satisfactory and which retains such characteristics during its safe storage. light, at room temperature, before opening.
- the present invention relates to a lipid composition containing more than 97%, and preferably more than 97.8% of lipids of plant origin and comprising in total:
- DHA docosahexaenoic acid
- EPA eicosapentaenoic acid
- a first, lipidic, aromatic and flavoring substance such as a vegetable oil or unrefined taste spre e g, other than olive oil, in particular selected from virgin oils hazelnut, macadamia, almond, avocado, camelina, walnuts, prune almonds, sesame, flax, roasted or roasted dried fruit oils, roasted or roasted seed oils or any combination of these oils between them,
- lipid composition having the following properties:
- the refined or unrefined rapeseed oils contain from 7 to 11% of alpha-linolenic acid and more particularly from 7.5 to 10.5% of alpha-linolenic acid.
- composition defined above has in particular been packaged in opaque PET bottles.
- Such a lipid composition is particularly suitable for people who need a DHA supplement via their diet, that is to say people who do not reach at least the recommendations of the Recommended Dietary Intakes, those whose diet is unbalanced or people with special needs, such as pregnant or breastfeeding women or elderly people.
- the oil of rapeseed ensures the necessary intake of alpha-linolenic acid ( ⁇ 3) and a good content of monounsaturated fatty acids while the high oleic acid sunflower oil avoids bringing too much omega 6 fatty acids while being a source of vitamin E; one or more lipid ingredients rich in DHA and comparatively low in EPA, by selecting high DHA and low EPA fish oils and / or high DHA and low microalgae oils EPA content;
- oily preparation of synthetic d-1-alpha-tocopherol acetate and / or oily natural extract rich in alpha-tocopherol optionally an oily preparation of vitamin D, for example vitamin D3.
- the Applicant has advantageously found that the combination of organoleptic masking means and physical protection against light makes it possible to obtain formulas of said lipid composition whose organoleptic characteristics remain satisfactory during its aging at room temperature and before opening. On the contrary, without the use of this combination of organoleptic masking and protection against light, the composition can undergo a rapid organoleptic alteration at room temperature.
- the Applicant has found that the use of natural antioxidants can also contribute, but to a lesser extent, to enhancing the organoleptic stability of said composition, without resorting to the use of anti-oxidants. Oxygen chemicals.
- the originality of the present invention consists in the use of one or several vegetable oils with unrefined or virgin taste, other than olive oil, which confer tastes adapted to the different culinary applications of edible oils.
- the plaintiff has sought an unrefined or virgin vegetable oil other than olive oil that can:
- hazelnut oil comprising nearly 80% monounsaturated fatty acids, less than 15% linoleic acid and less than 0.5% alpha linolenic proves to be an aromatic substrate of excellent physicochemical stability.
- the virgin hazelnut oil may or may not be roasted, under conditions of time and temperature avoiding the appearance of flavors of "burnt".
- the masking by the virgin hazelnut oil notes sui-generis and tastes of weathering of DHA-rich oils and refined rapeseed oils is satisfactory and gives the composition, at contents of about 0.3% to 2% of virgin hazelnut oil, a fine taste and delicate considered satisfactory by the majority of panelists who evaluated the lipid composition.
- the preservation of the claimed composition in opaque bottles of colored and opacified PET with titanium oxide is suitable.
- a fortiori the composition claimed is also well preserved when it is packaged in completely opaque containers to light, such as for example metal cans varnished internally.
- the rapeseed oil used may be either refined rapeseed oil or a mixture comprising a majority of refined rapeseed oil and another part of unrefined rapeseed oil and / or or roasted or roasted rapeseed oil.
- the lipid composition of the present application is novel in that it thus makes it possible to simultaneously achieve two objectives of interest:
- a nutritionally improved lipidic intake characterized by the introduction of DHA into the composition, preferably with EPA, together with a substantial supply of alpha-linolenic acid, in an optimized ratio between the omega 6 and omega 3 fatty acids, conferring on the claimed composition a "balancing" oil role for the daily diet with a significant contribution of omega 3 precursor (alpha-linolenic) and its long-chain omega 3 (DHA) derivative, covering with two spoons 10 g at least 50% of the Inputs
- the masking of the undesirable tastes of the claimed composition can be realized, that these bad tastes come from the sui-generis taste of the ingredients rich in DHA and rapeseed oils or that they are generated during the aging of the composition in time.
- the weight ratio linoleic acid / alpha-linolenic acid ranges from 2.4 to 3.9, and especially from 2.6 to 3.9, allowing the lipid composition to play its role as a balancing composition in the daily diet.
- the weight ratio oleic acid / linoleic acid varies from 3.1 to 4, which allows to better control the physicochemical environment of omega 3 alpha-linolenic and docosahexaenoic fatty acids and to reduce the oxidative stress potential of the lipid composition.
- the oleic acid / alpha-linolenic acid weight ratio varies from 9 to 14, which guarantees a suitable balance between the oleic monounsaturated fatty acid ( ⁇ 9) and the group of fatty acids of the omega 3 series of the lipid composition, allowing thus optimize the environment of these polyunsaturated fatty acids.
- the weight ratio alpha-linolenic acid / docosahexaenoic acid ranges from about 7 to about 30, making it possible to supplement, within the omega 3 family, the supply of alpha-linolenic acid by a sufficient amount of DHA, in order to compensate the lack of human conversion of alpha-linolenic acid to DHA.
- the ratio by weight (docosahexaenoic acid) / (eicosapentaenoic acid) varies from about 4 to about 160, which reflects the desired selective enrichment in long-chain omega-3 derivative C22 and six unsaturations (DHA), the contribution of eicosapentaenoic acid (EPA) is not considered essential in the production of the claimed lipid composition. Indeed, in his patent application FR
- lipid composition from about 0.25% to about 0.75%, especially from about 0.30 to about 0.65%, particularly from about 0.25 to about 0.65% DHA, by weight of the lipid composition,
- the lipid composition claimed is therefore designed to contain less than about 100 mg EPA per 100 g of composition.
- DHA DHA
- the conversion rate of EPA to DHA is considered to be low, of the order of the% in the human, the man in particular, and that the Recommended Dietary Intakes for the population (ANC 2001) of 120 mg of DHA per day in adult men, 100 mg in adult women, 250 mg in pregnant or breastfeeding women, 100 mg in the elderly are not affected in all patients. people.
- the DHA content of the lipid composition according to the invention is therefore from about 250 mg to about 750 mg, in particular from about 250 mg to about 650 mg of DHA per 100 g of composition.
- Two tablespoons of 10 g of the claimed composition thus advantageously provide between about 50% and about 125%, especially between about 50% and about 100% of the recommended daily intakes.
- the total EPA and DHA content is in a range of from about 300 mg to about 850 mg, particularly from about 300 mg to about 750 mg of omega 3 fatty acids per 100 g of the claimed lipid composition.
- the lipid composition of the invention is characterized in that it comprises:
- the lipid composition according to the invention is also characterized in that it comprises from about 63 to about 70%, and preferably from about 65 to about 69% by weight of oleic monounsaturated acid ( ⁇ 9).
- Rapeseed oils (Canola), high oleic sunflower oils (eg Oléisol®) and high oleic acid and low alpha-linolenic acid rapeseed oils are among the main sources of oleic acid of the claimed composition.
- the lipid composition of the invention comprises from about 15 to about 19%, and preferably from about 16 to about 18% by weight of linoleic polyunsaturated acid ( ⁇ 6).
- Rapeseed oils, high oleic sunflower oils and high oleic acid rapeseed oils with low levels of linoleic acid (less than
- the lipid composition of the invention is characterized in that it comprises from about 5.0 to about 7.2%, particularly from about 5.0 to about 7.0%, and preferably from about 5.3 to about 6.9% by weight alpha-linolenic polyunsaturated acid (omega 3).
- the Applicant has advantageously found that the combination of organoleptic masking means and physical protection against light makes it possible to obtain formulas of said nutritional lipid composition whose organoleptic characteristics remain satisfactory during aging at room temperature before opening, when said composition comprises simultaneously from about 5% to about 7.2%, especially from about 5.0 to about 7.0% by weight of alpha-linolenic acid ( ⁇ 3) and from about 0.25% to about 0.75%, especially from about 0.25 to about 0.65% by weight of docosahexaenoic acid ( ⁇ 3).
- One of the nutritional aspects of the present invention is therefore to provide a nutritional lipid composition which guarantees on the one hand a significant contribution of alpha-linolenic acid ( ⁇ 3) of from about 5 g to about 7.2 g, in particular from about 5 g to about 7 g per 100 g of lipid composition and, on the other hand, a significant contribution of docosahexaenoic acid ( ⁇ > 3) (DHA) of from about 250 mg to about 750 mg, particularly about 250 mg.
- alpha-linolenic acid ⁇ 3
- DHA docosahexaenoic acid
- alpha-linolenic acid fatty acid of formula Cl 8: 3 with three non-conjugated double bonds means the total alpha-linolenic acid, mainly comprising the isomeric form “garlic cis” ("all cis”). ) and low isomeric forms “trans” from the vacuum deodorization operation at a temperature in the region of 200-220 ° C.
- deodorizations carried out according to good manufacturing practices lead in the case of rapeseed oils to levels of at least 93% of the form "garlic cis" nutritionally sought, that is to say a degree of isomerization of the alpha-linolenic acid of refined rapeseed oil less than 7%.
- linoleic acid fatty acid of formula Cl 8: 2 with two non-conjugated double bonds means total linoleic acid, comprising for the most part the isomeric form “cis garlic” ("all cis”) and at very low content the isomeric "trans” form.
- Good deodorising manufacturing practices for oils rich in linoleic acid lead to levels of at least 99.5% of the nutritionally desirable "garlic cis” form, ie a degree of isomerisation of the linoleic acid less than 0.5%.
- docosahexaenoic acid ( ⁇ 3) or DHA a fatty acid of formula C22: 6 with six non-conjugated double bonds, essentially means the isomeric form
- the supply of alpha-linolenic acid ( ⁇ 3) ensures that the claimed composition is between about 5 g and about 7.2 g, in particular between about 5 g and about 7 g of alpha-linolenic acid per 100 g of composition lipid, thus helping to cover a large part of the daily needs evaluated at 2 g in adult men, as defined in the Recommended Dietary Intakes for the French Population (ANC 2001).
- Two tablespoons of 10 g of the oil of the claimed composition thus provide advantageously between about 50% and about 70% of the recommended daily intakes.
- the supply of docosahexaenoic acid (DHA) that the claimed composition guarantees is between about 250 mg and about 750 mg, particularly between about 250 mg and about 650 mg of docosahexaenoic acid per 100 g of oil, contributing thus to cover a large part of the daily needs currently fixed at 120 mg in the adult man, as recommended in the Recommended Dietary Intakes for the French population (ANC 2001).
- Two tablespoons of 10 g of the oil of the claimed composition thus advantageously provide between about 50% and about 125%, especially between about 50% and about 100% of the recommended daily intakes.
- Rapeseed oil is the main source of alpha-linolenic acid of the composition of the invention. It can not be replaced in whole or in majority by soya oil, the latter bringing too much linoleic acid
- the lipid composition of the invention is characterized in that the ratio by weight of monounsaturated fatty acids and polyunsaturated fatty acids varies from about 2.4 to about 3.5, and preferably from about 2.5 to about 3.3.
- This report illustrates the monounsaturated environment of this lipid composition enriched in DHA, to ensure the protection of the latter and to fight against oxidative stress in the user of the claimed composition, together with the presence of vitamin E, without as much neglect a minimum intake of linoleic essential fatty acid of between about 15% and about 19% by weight of the composition.
- An advantageous lipid composition according to the invention is characterized in that the ratio by weight of omega-6 fatty acids to omega-3 fatty acids varies from about 2.4 to about 3.9, in particular about 2.6. at about 3.9 and preferably from about 2.6 to about 3.3.
- the weight ratio linoleic acid / alpha-linolenic acid ( ⁇ 6 / ⁇ 3) varies from 2.4 to 3.9, and in particular from 2.6 to 3.9, this range allowing the lipid composition to play a role of balancing oil in the daily lipid diet by bringing between about 5.0 g and about 7.2 g, in particular between about 5 g and about 7 g of alpha-linolenic acid per 100 g of lipid composition, but without adding more than about 15 g to about 19 g of linoleic acid per 100 g of lipid composition.
- the daily intake of two tablespoons of 10 g of the claimed composition thus covers at least 50% of the ANC alpha-linolenic acid, without exceeding 35% of the ANC linoleic acid.
- the lipid composition of the invention has a weight ratio between oleic acid and DHA which varies from about 90 to about 280, and in particular from about 100 to 250 and preferably from about 110 to about 240. This means that, unlike other formulations proposed in the state of the art, DHA is protected by sufficient coverage of monounsaturated fatty acids.
- the lipid composition of the invention is characterized in that it contains a vitamin E content, expressed as alpha-tocopherol equivalent (TE), of between about 0.03% and about 0, 10% by weight of the lipid composition.
- TE alpha-tocopherol equivalent
- the vitamin E intake of the claimed composition is at least about 30 mg of natural alpha-tocopherol equivalent (TE) per 100 g of composition or at least about 45 mg of alpha acetate equivalent.
- tocopherol (IU) per 100 g of composition thanks to the natural richness of the oils of the composition in tocopherols and by a possible complementation of d-1-alpha-tocopherol acetate of ⁇ yn hese or natural extracts rich in alpha-tocopherol .
- Two tablespoons of 10 g of the lipid composition thus advantageously provide at least 90% of the RDAs fixed at 10 mg (IU) of vitamin E per day.
- the vitamin E intake of the claimed composition is at most about 100 mg of natural alpha-tocopherol equivalent (TE) per 100 g of composition or at most about 150 mg of alpha acetate equivalent.
- tocopherol (IU) per 100 g of composition, thanks to the natural richness of the oils of the tocopherol composition and by a possible complementation of synthetic d-1-alpha-tocopherol acetate or natural extracts rich in alpha-tocopherol.
- the lipid composition of the invention is also characterized in that it contains a vitamin E content, expressed as alpha-tocopherol acetate (UI) equivalent, of between about 0.05% and about 0.15%, by weight of the lipid composition. It is also characterized in that the weight ratio of alpha-tocopherol to gamma-tocopherol ranges from about 0.7 to about 2.3 and preferably from about 1.2 to about 2.0.
- composition of the invention has the originality of simultaneously containing amounts of ⁇ -tocopherol and ⁇ -tocopherol of the same order of magnitude.
- biological antioxidant ⁇ -tocopherol (anti-radical vitamin E activity) and ⁇ -tocopherol recognized “technological antioxidant”, but also the possible complementary effect of gamma-tocopherol vis-à-vis the alpha tocopherol at the biological level (Saldden K., Saldeen Tom, Nutrition Research 25 (2005): 877-889).
- the lipid composition of the invention is characterized in that the vitamin D content varies from approximately 10 to approximately 150 ⁇ g per kg of lipid composition, in particular from approximately 40 to 60 ⁇ g per kg of lipid composition.
- the vitamin D content of the claimed composition ranges from about 10 ⁇ g to about 150 ⁇ g of vitamin D per kg of lipid composition, according to the regulations in force in each country.
- the vitamin D intake of the composition claimed is in France at a regulatory maximum of 5 ⁇ g of vitamin D per 100 g of composition. Two tablespoons of 10 g of the composition thus provide in France 20% of the needs fixed at 5 ⁇ g of vitamin D per day.
- An advantageous lipid composition according to the invention is characterized in that the total trans isomeric fatty acid content is less than about 0.8%, and preferably less than about 0.5%, by weight of the lipid composition.
- the lipid composition that is the subject of the invention contains less than 0.10% of trans isomers of linoleic acid. Likewise it contains less than 0.7% trans isomers of alpha-linolenic acid, and preferably less than about 0.5%.
- the lipid composition according to the invention does not contain trans isomers of docosahexaenoic acid (DHA).
- the lipid composition according to the invention does not contain trans isomers of docosahexaenoic acid (DHA).
- the lipid composition of the invention is characterized in that the ratio by weight between the lipid content of marine origin and / or microalgal and the content of vegetable oil with unrefined taste or virgin other than the olive oil is from about 0.1 to about 30, in particular from about 0.3 to about 30, in particular from about 0.1 to about 22, in particular from about 0.6 to about 7, and preferably from about 0.4 to about 7.
- the present invention also relates to a lipid composition as defined above, wherein the vegetable oil containing less than 4% of alpha-linolenic acid and containing from about 72% to about 92% of oleic acid is selected from high oleic sunflower, high oleic acid and low alpha-linolenic rapeseed oil, high oleic safflower oils, high oleic acid peanut oils, hazelnut oils, almond oils or their mixtures.
- the rapeseed oil can be usefully replaced or supplemented in small amounts with linseed oil or camelina oil or perilla oil or dill oil. inca inchi or kiwi seed oil or their mixtures.
- oils containing more than 25%, and in particular more than 30% of alpha-linolenic acid, make it possible to guarantee a minimum alpha-linolenic acid content of the composition claimed when the rapeseed oil contains little for varietal and / or climatic reasons.
- the present invention also relates to a lipid composition as defined above, in which the rapeseed oil is partially replaced or supplemented with linseed oil at a flaxseed oil content of from about 0.5% to about 4%, and preferably from about 1% to about 3%, by weight of the lipid composition.
- the present invention also relates to a lipid composition as defined above, in which the rapeseed oil is partially replaced or supplemented with perilla oil at a perilla oil content of from about 0.5% to about 4%, and preferably from about 1% to about 3%, by weight of the lipid composition.
- the present invention also relates to a lipid composition as defined above, in which the rapeseed oil is partially replaced or supplemented with inca inchi oil at an inca inchi oil content of approximately 0.5 about 4%, and preferably about 1% to about 3%, by weight of the lipid composition.
- the present invention also relates to a lipid composition as defined above, wherein the rapeseed oil is partially replaced or supplemented with kiwifruit seed oil to a content of kiwifruit seed oil from about 0.5% to about 4%, and preferably from about 1% to about 3%, by weight of the lipid composition.
- the present invention also relates to a lipid composition as defined above, in which the rapeseed oil is partially replaced or supplemented with camelina oil at a camelin oil content of approximately 0.5% to about 9%, and preferably about 1% to about 8%, by weight of the lipid composition.
- the present invention also relates to a lipid composition as defined above, in which the natural content of vitamin E (alpha-tocopherol) of the oils of the composition is completed by the addition of natural alpha-tocopherol at a rate of approximately 0.004% to about 0.08%, and preferably about 0.01% to about 0.06%, by weight of the lipid composition.
- vitamin E alpha-tocopherol
- the lipid composition of the invention is characterized in that the natural content of vitamin E (alpha-tocopherol) of the oils of the composition is completed by the addition of alpha-tocopherol acetate of synthesis from about 0.006% to about 0.12%, and preferably from about 0.015% to about
- the lipid composition of the invention is characterized in that the natural content of vitamin E (alpha-tocopherol) of the oils of the composition is completed by the addition of an antioxidant mixture of natural tocopherols to levels ranging from about 0.01% to about 0.05%, and preferably from about 0.02% to about 0.04%, by weight of the lipid composition.
- vitamin E alpha-tocopherol
- the lipid composition of the invention is characterized in that the first aromatic and flavoring substance is a virgin hazelnut oil, optionally roasted, the content of which is from about 0.1% to about 8%, preferably from about 0.2% to about 5%, and more preferably from about 0.3% to about 2% by weight of the lipid composition.
- the first aromatic and flavoring substance is a virgin hazelnut oil, optionally roasted, the content of which is from about 0.1% to about 8%, preferably from about 0.2% to about 5%, and more preferably from about 0.3% to about 2% by weight of the lipid composition.
- the present invention also relates to a lipid composition as defined above, wherein the second aromatic and flavoring substance is a citrus essential oil whose content ranges from about 0.001% to about 0.010% by weight of the composition lipid.
- the present invention also relates to a lipid composition as defined above, characterized in that it contains natural antioxidant extracts rich in phenolic compounds, especially rosemary or sage extracts, from about 0.005% to about 0.2% by weight of the lipid composition.
- the present invention also relates to a lipid composition as defined above, characterized in that it is supplemented with retinol (vitamin A), in particular at levels of from about 5,000 to about 15,000 ⁇ g retinol per kg. .
- retinol vitamin A
- Vitamin A is indeed needed in some parts of the world or in people with more or less deficiency of retinol.
- the composition may thus contain the three liposoluble vitamins A, D and E.
- the present invention also relates to a lipid composition as defined above, characterized in that it is supplemented with ⁇ -carotene.
- Vitamin A in particular at levels of about 30 to about 90 mg of ⁇ -carotene per kg of lipid composition.
- ⁇ -carotene is the precursor of vitamin A and it is also an anti-radical substance that protects against certain pathologies by reducing oxidative stress.
- the present invention also relates to a lipid composition as defined above, characterized in that it comprises:
- the lipid composition of the invention comprises:
- the lipid composition of the invention comprises: - about 63 to about 77% of refined rapeseed oil,
- the lipid composition of the invention comprises:
- the peptide composition of the invention comprises: approximately 70% of refined rapeseed oil
- the lipid composition of the invention comprises:
- the present invention also relates to a lipid composition as defined above, in particular a food vegetable oil, intended for use as seasoning oil, cooking oil, or multipurpose oil.
- the present invention also relates to a food composition, in particular an aromatic and / or aromatized oily preparation, in which the lipid composition consists of any of the lipid compositions as defined above.
- the present invention also relates to a food composition, in particular a condiment preparation, emulsified or not, based on vegetable oil, in particular mayonnaise, lightened mayonnaise, sauces for salads and crudity, salad dressings, light salad dressings, culinary sauces, intended for seasoning or the accompanying dishes, wherein the lipid composition is constituted by any of the lipid compositions as defined above.
- the present invention also relates to a food composition, especially food supplements such as in particular capsules or capsules, wherein the lipid composition is constituted by any of the lipid compositions as defined above.
- the present invention also relates to a food composition, in particular a composition based on milk and / or dairy derivatives, in particular creams, fermented milks, yoghurts, sauces, cheeses and milk desserts, in which the lipid composition is constituted by any one of the compositions lipid as defined above.
- the invention is illustrated hereinafter by examples of compositions, dark storage laboratory tests and accelerated aging tests in light, and finally pilot scale achievements of the claimed composition.
- the refined rapeseed oil is taken from the refined rapeseed storage tank of the LESIEUR de Coudekerque-Branche plant. Its oleic acidity is less than 0.1%, its moisture is less than 0.07%, its alkalinity is less than 6 ppm, its peroxide number is less than 1 meq / kg and its phosphorus content is less than 5 ppm. It is considered neutral taste.
- Refined sunflower oil with high oleic acid content (Oleisol®) is collected from the refined Oleisol® storage tank at the LESIEUR plant in Coudekerque-Branche. Its oleic acidity is less than 0.1%, its moisture content is less than 0.07%, its alkalinity is less than 6 ppm, its peroxide number is less than
- the high oleic acid and low oleic acid refined rapeseed oil comes from the ITERG (F-Pessac) refinery. Flaxseed oil is a commercial, cold-pressed, unrefined and good-quality organoleptic pressure oil.
- Camelina oil is a virgin, commercially available, high quality organoleptic oil.
- the virgin hazelnut oil possibly roasted, of French origin, contains about 80% oleic acid, 11% linoleic acid and less than 2% alpha-linolenic acid.
- compositions obtained were packaged in bottles for use in the various tests (accelerated aging tests in light or commercial type preservation tests in cartons):
- composition in% and the tocopherol content of these compositions are the composition in% and the tocopherol content of these compositions.
- LA linoleic acid ( ⁇ 6)
- ALA alpha-linolenic acid ( ⁇ 3)
- DHA docosahexaenoic acid
- ANC recommended dietary allowance (Recommended Dietary Intakes for the French population -ANC 2001 - 3rd Edition - Editions Tec & Doc).
- Alpha-linolenic acid 2 g / day (ANC)
- DHA 120 mg / day (ANC) ⁇ -tocopherol (IU) 10 mg / day (AJR)
- Example 1 Laboratory tests with accelerated aging test in the light
- formulas of the lipid composition have were prepared in quantities of 10 kg based on an oily mixture containing 75% by weight of refined rapeseed oil and between 23% and 25% of high oleic sunflower oil (Oléisol®), with 100% adjustment of the formula depending on the content of the other ingredients.
- the refined rapeseed oil contains 61.1% oleic acid, 20.2% linoleic acid and 8.6% alpha-linolenic acid.
- Oléisol ⁇ (Lesieur) oil contains 85.5% oleic acid, 6.0% linoleic acid and less than 0.5% alpha-linolenic acid.
- the virgin hazelnut oil, possibly roasted, is of French origin.
- the first DHA-rich fish oil comes from the company Lipid Nutrition (Wormerveer, The Netherlands) under the reference “Marinol TM D-40" and contains about 36% DHA and 6% EPA.
- the second fish oil rich in DHA comes from the company DSM
- Nutritional Products Europe Ltd (Basel, Switzerland) under the reference 'Ropufa ®' 30 'n-3 INF oil' and contains approximately 27% DHA and 6% EPA.
- the DHA-rich algal oil comes from the Nutrinova Company (Frankfurt-am-Main, Germany) under the reference "Nutrinova® DHA CL" and contains about 43% DHA and 0.4% EPA.
- the different formulas prepared were produced in quantities of 10 kg by mixing the various pre-weighed ingredients in a 15 liter stainless steel bucket, with a moderate stirring (without vortexing) at 600 rpm for 20 minutes, using an electric blade agitator type Turbotest Rayneri (Company VMI, Montaigu, France), thus avoiding harmful aeration of the composition.
- TO indicator rapeseed oil 7500 g Oléisol® oil 2500 g
- Tl indicator rapeseed oil 7500 g Oléisol® oil 2450 g virgin hazelnut oil 50 g
- Formula AO rapeseed oil 7500 e oil Oléisol® 2425 g oil Nutrinova®DHA-CL 75 g
- FormulaAl rapeseed oil 7500 g Oléisol® oil 2375 g Nutrinova®DHA-CL oil 75 g virgin hazelnut oil 50 g
- Formula RO rapeseed oil 7500 g oil Oléisol® 2380 g oil Ropufa®'30'n-3 INF oil 120 g
- Formula R rapeseed oil 7500 g oil Oléisol® 2330 g oil Ropufa®'30'n-3 INF oil 120 g virgin hazelnut oil 50 g
- rapeseed oil 7500 g Oléisol® oil 2425 g Marinol TM oil D-40 75 g
- This test also shows that without the presence of an unrefined vegetable oil, such as in particular the virgin hazelnut oil, optionally roasted, the formulas of the lipid composition containing oils rich in DHA, whether these come from fish or microalgae, withstand the aging test less well or poorly, with fish and / or rancid notes, especially if these DHA-rich oils had a sui-generis taste of fish from the start.
- an unrefined vegetable oil such as in particular the virgin hazelnut oil, optionally roasted
- lipid composition prepared in amounts of 1500 g based on an oily mixture containing 890 g of refined rapeseed oil.
- the objective is to study the effect of the different ingredients on the organoleptic quality of lipid compositions.
- Refined rapeseed oil contains 61.6% oleic acid, 20% linoleic acid and 8.7% alpha-linolenic acid.
- Oléisol® (Lesieur) oil contains 81.7% oleic acid, 9.3% linoleic acid and less than 0.5% alpha-linolenic acid.
- the virgin hazelnut oil possibly roasted, of French origin, contains 80% oleic acid, 11% linoleic acid and less than 0.5% alpha-linolenic acid.
- the fish oil rich in DHA comes from the company Lipid Nutrition (Wormerveer, The Netherlands) under the Marinol TM D-40 reference and contains about 36% DHA and 6% EPA.
- the oily solution rich in natural tocopherols with antioxidant effect comes from the company Vitablend (Wolvega, the Netherlands) under the reference Tocoblend TM
- L50 IP contains about 50% mixture of natural tocopherols (mainly gamma-tocopherol) and 50% of sunflower oil.
- the citrus essential oil comes from the company René Laurent SAS (Le Cannet-France).
- the hazelnut oil and fish oil rich in DHA were used as is, while the solution rich in natural tocopherols and citrus essential oil were pre-diluted under form of a 1% by weight stock solution in Oleisol® oil.
- the fish oil rich in DHA was dosed at the rate of
- the nine different formulas prepared were made by mixing the various pre-weighed ingredients in a 5-liter container, with moderate agitation, without creating vortices, at 500 rpm for 20 minutes, using an electric stirrer. with blades Turbotest Rayneri type (Society VMI, Montaigu, France), thus avoiding the aeration detrimental of the composition.
- T indicator rapeseed oil 900 g Oléisol® oil 600 g
- Formula M rapeseed oil 900 g Oléisol® oil 587g Marinol TM oil D-40 13.5 g
- Formula N rapeseed oil 890 g Oléisol® oil 589 g Marinol TM D-40 oil 13.5 g virgin hazelnut oil 7.5 g
- Formula C rapeseed oil 890 g Oléisol® oil 593 g Marinol TM oil D-40 13.5 g citrus care @ 1%
- rapeseed oil 890 g Oléisol® oil 552 g Marinol TM D-40 oil 13.5 g Tocoblend TM solids @ l% 45 g
- rapeseed oil 890 g Oléisol® oil 585 g Marinol TM oil D-40 13.5 g virgin hazelnut oil 7.5 g citrus fruit care @ 1% 4 g
- Formula VN rapeseed oil 890 g Oléisol® oil 544 g Marinol TM oil D-40 13.5 g virgin hazelnut oil 7.5 g Tocoblend TM care @ 1% 45 g
- CVN formula rapeseed oil 890 g Oléisol® oil 540 g Marinol TM oil D-40 13.5 g virgin hazelnut oil 7.5 g Tocoblend TM care @ 1% 45 g citrus fruit care @ 1% 4 g
- Each formula was then poured into 60 ml glass vials (50 g oil) sealed and stored in different storage conditions:
- the control T has a slight taste of "green-bean / raw seed", without taste of fish.
- Test M also has a slight taste of "green-bean / raw seed", without taste of Doisson.
- Test N has a slight nutty taste, and there is no taste for "green-bean / raw seed” and fish.
- Test C has a slight lemon-like taste, and there was no taste for "green-bean / raw seed” and fish.
- Test V has a slight taste of "green-bean / raw seed", but no fish.
- the CV test has a slight taste of "green-bean / raw seed" a little attenuated, and no taste of fish.
- the CN test has a slight nutty flavor, a little reduced by the presence of the lemon-like taste, and there was no taste of "green-bean / raw seed" and fish.
- the VN test has a slight nutty taste, and there was no taste for "green-bean / raw seed” and fish.
- the CVN test has a slight hazelnut flavor, a little attenuated, and there is no taste for "green-bean / raw seed” and fish.
- the control T has a slight taste of "green-bean / raw seed", without taste of fish, with a note of 7.3 correct.
- Test M also has a slight taste of "green-bean / raw seed” and in addition a slight taste of fish, with a score of 6.7 unsatisfactory since below the threshold limit of 7.0.
- Test N has a pleasant nutty taste, and the absence of bad taste was noted, with a rating of 7.4 correct.
- Test C has a slight lemon-like taste, and a slight fish note, with a rating of 7.0.
- Trial V has a slight "green-bean / raw-seed” taste, and a slight fishy note, with a rating of 7.0.
- the CV test has a slight taste of "green-bean / raw seed", and a slight note of fish, with a score of 7.0.
- the CN test has a slight nutty taste, attenuated by the lemon-like taste, and the lack of fish taste was noted, with a rating of 7.3 correct.
- the VN test has a slight nutty taste, and the lack of fish taste was noted, with a rating of 7.4 correct.
- the CVN test has a slight hazelnut taste, a little attenuated, and the lack of fish taste was noted, with a rating of 7.3 correct.
- the products subjected to accelerated aging in natural light of the inner day as defined above and at room temperature were observed after 5 weeks of exposure. Their ratings are more or less satisfactory, or even mediocre, according to the formulas (notes between 5.3 and 7.5 / 10):
- the witness T presents a taste of "green-bean", like fish, of old rapeseed, with a note of 5.7 crippling.
- Test M has a disgusting taste of disgusting fish, accompanied by a characteristic oxidative rancidity taste, with a note of 5.3 crippling.
- Test N has a slight taste of hazelnut, a little "fatty butter”, not bad taste especially no fish, with a note of 7, 1 correct. The nutty note is described as "old hazelnut”.
- Test C has a slight lemon-like taste and then a note of fish, rated 6.3 mediocre.
- Trial V has a "green-bean" note with a slight fishy taste, rated 6, 1 mediocre.
- the CV test also has a fish note, with a lemon-like aftertaste, rated 6.3 mediocre.
- the CN test has barely a nutty taste, without the qualifier of "old hazelnut”, little “butter fat”, slightly like lemon on the finish, without fish taste, no bad taste with a score of 7, 1 correct.
- the VN test has a very slight hazelnut taste, a little "greasy butter”, a slight taste of "green-bean”, no fish taste, no bad taste with a note of 7, 1 correct.
- the CVN test has a slight nutty taste, without the qualifier of "old hazelnut”, not “butter”, barely a lemon on the finish, overall fairly balanced and quite neutral, not bad taste with a note of 7.3 correct.
- CVN formula which is characteristic of the composition claimed, contains in% by weight: rapeseed oil 59.33% Oléisol® oil 39.24% Marinol TM oil D-40 0.90% virgin hazelnut oil 0.50%
- the chromatographic composition of the fatty acids of this formula corresponds to the expected lipid composition, in particular to claims 1 to 14 (Tables 2 and 3). TABLE 2 ANALYSIS OF THE FATTY ACID COMPOSITION OF THE LABORATORY TEST
- a quantity of 300 kg of lipid composition was prepared on a pilot scale.
- Refined rapeseed and high-oleic refined sunflower oils (Oleisol®) for composition were shipped from the storage tanks of the Lesieur plant to the R & D Lesieur Pilot Laboratory in 200 kg drums.
- Refined rapeseed oil contains 62% oleic acid, 20% linoleic acid and 8.2% alpha-linolenic acid.
- Oléisol® oil contains 85% oleic acid, 7% linoleic acid and less than 0.5% alpha-linolenic acid.
- the DHA-rich fish oil used is from Nippon Chemical Feed Co. Ltd. (Hakodate, Hokkaido, Japan) as DHA-27HD and contains about 28% DHA and 5.9% EPA.
- the oily solution rich in natural tocopherols with antioxidant effect comes from the company Vitablend (Wolvega, the Netherlands) under the reference Tocoblend TM
- L50 IP contains about 50% mixture of natural tocopherols (mainly gamma-tocopherol) and 50% of sunflower oil.
- the citrus essential oil comes from the company René Laurent SAS (Le Cannet-France).
- the oily solution of vitamin D contains 4500 mg of vitamin D3 per kg of solution and was prepared by predilution in Oleisol® of an oil solution containing 1 000 000 IU of vitamin D3 from DSM Nutritional Products Europe Ltd (Basel, Switzerland).
- the formula of the lipid composition comprises for 300 kg manufactured: 72% of refined rapeseed oil (ie 216 kg)
- rapeseed oil and 78 kg of Oléisol® are transferred from their casks to the 600 liter stainless steel tank, avoiding any aeration. untimely oils.
- the transfer is carried out using a variable speed flow pump drum pump (body F430SL, motor F417EL, Company FLUX-Gerate GmbH, Maulbronn, Germany) after weighing the drums on a pallet truck-weigher "Ravas RPW4100 "strain gage (Ravas Mobile Weighing Company, Zaltbommel, the Netherlands).
- the mixture of fish oils rich in DHA and virgin hazelnut was prepared in a 10-liter stainless steel bucket, to which were added the other minor ingredients (natural tocopherol, vitamin D, citrus essential oil).
- This mixture is stirred moderately for 20 minutes without vortexing using a Turbotest Rayneri electric stirrer (Sté VMI, Montaigu, France) rotating at 500 rpm.
- This oily preparation of 4.82 kg was then poured into the premix rapeseed-Oleisol® 294 kg and completed after rinsing with 1.2 kg of Oléisol®.
- the mixture in the tank was made homogeneous by the moderate stirring of the "Rayneri” deflocculating propeller mixer (Institut VMI, Montaigu, France) of the 600 liter stainless steel tank rotating at 450 rpm for a period of 30 minutes, without vortex formation.
- the lipid composition obtained was then transferred using a volumetric doser "Stoppil-Super” equipped with a manual control (Institut Stoppil SA, Marne-la-Vhui, France) in:
- the chromatographic composition of the fatty acids of the composition obtained corresponds to the expected lipid composition, in particular to Claims 1 to 14 (Tables 4 and 5).
- Example 4 Second pilot manufacture.
- Refined rapeseed oil contains 63% oleic acid, 19.5% linoleic acid and 7.9% alpha-linolenic acid.
- Sunflower oil with high oleic acid content 63% oleic acid, 19.5% linoleic acid and 7.9% alpha-linolenic acid.
- Oléisol® virgin hazelnut oil, oily solution rich in natural tocopherols, oily Vitamin D solution and citrus essential oil used have the same characteristics as in the previous examples.
- the DHA-rich fish oil used comes from the company Lipid Nutrition (Wormerveer, The Netherlands) under the Marinol TM D-40 reference and contains about 36% of
- the formula of the lipid composition comprises for 300 kg manufactured: 71.67% of refined rapeseed oil (ie 215 kg)
- Example 2 The nine different formulas prepared in Example 2, in 60 ml glass flasks and kept in the dark at room temperature in closed cartons, were evaluated sensory after 6 months of aging under these conditions of conservation.
- Test T neutral odor light taste of "green seed", no other defects, grade 7.3
- Test M smell of green and fish taste pronounced, disgusting and unacceptable fish, note 5.7
- Test V slight fish odor fish taste not prohibitive but persistent in the mouth, note 6.5
- Test C light odor slight taste of lemon then fish, lemon aftertaste, fresh, note 6.9
- Test N slight hazelnut flavor slight hazelnut taste a little "fat”, no fish taste, homogeneous without defects, note 7.6
- Test VN slight hazelnut smell slight nutty taste a little "fat”, no fish taste, homogeneous without defects, note 7.6
- test M containing the fish oil rich in DHA does not reach a correct score, even stored in the dark, when the composition does not contain at least the first aromatic lipid substance and claimed sapid;
- a first lipid substance, aromatic and sapid such as an unrefined or virgin vegetable oil, other than olive oil, allows, as in the example cited with hazelnut oil virgin, possibly roasted, dosed less than 1%, perfectly mask the fish taste and ensure organoleptic stability, correct after exposure to light for 5 weeks and satisfactory after dark storage for a period of at least minus 6 months;
- Pilot test no. 1 (example 3): light hazelnut smell pleasant slight nutty flavor, no "fat seed” sensation, no fish taste, no "green bean / raw seed” taste, no flaws balanced with a little freshness on the finish, satisfactory note of 7.7.
- Pilot test n ° 2 (example 4): light hazelnut smell pleasant slight nutty taste, lack of "fat seed” sensation, no fish taste, no taste of "green bean / raw seed”, no defects balanced with a little freshness on the finish, satisfactory note of 7.7.
- lipid composition In an alternative embodiment of the lipid composition, all of the high oleic sunflower oil (Oleisol®) refined with an equal amount of a refined high oleic acid rapeseed oil were replaced. low alpha-linolenic acid content (LLHOR code).
- the lipid composition was made from:
- the lipid composition obtained had a satisfactory taste and its composition is given in the following tables 8 and 9 and corresponds to claims 1 to 14.
- rapeseed oil used has an insufficient alpha-linolenic acid content (7.4%) to guarantee the desired alpha-linolenic acid intake.
- the lipid composition was made from:
- high oleic sunflower oil (Oléisol®) containing 81.7% oleic acid, 9.3% linoleic acid and less than 0.5% alpha-linolenic acid.
- the resulting lipid composition has a satisfactory taste, with a good complementarity of the tastes of the virgin hazelnut oil and the virgin camelina oil, and its composition is given in the following Tables 10 and 11 and corresponds to the claims 1 at 14. TABLE 10 ANALYSIS OF THE FATTY ACID COMPOSITION OF THE "CAMELINE" TEST
- Example 9 Laboratory tests with addition of cold pressure linseed oil
- lipid composition 1% by weight of commercially available cold pressed commercial linseed oil, of good organoleptic quality, having not undergone treatment, was introduced into the formulation of the composition. proper refining and therefore no isomerization of alpha-linolenic acid.
- the rapeseed oil used at a rate of 73% is indeed too low in alpha-linolenic acid (7.4%) to reach the desired level of alpha-linolenic acid intake.
- the lipid composition was made from:
- the lipid composition obtained had a satisfactory taste, the two unrefined oils of flax and hazel being compatible in taste.
- the composition is given in the following tables 12 and 13 and corresponds to claims 1 to 14. TABLE 12
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
- Seasonings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0611077A FR2909839B1 (fr) | 2006-12-19 | 2006-12-19 | Composition lipidique presentant des proprietes d'interet |
| PCT/FR2007/001870 WO2008074936A1 (fr) | 2006-12-19 | 2007-11-13 | Composition lipidique présentant des propriétés d'intérêt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2101594A1 true EP2101594A1 (fr) | 2009-09-23 |
| EP2101594B1 EP2101594B1 (fr) | 2014-03-19 |
Family
ID=38230184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07870279.2A Active EP2101594B1 (fr) | 2006-12-19 | 2007-11-13 | Composition lipidique présentant des propriétés d'intérêt |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2101594B1 (fr) |
| BE (1) | BE1019597A5 (fr) |
| FR (1) | FR2909839B1 (fr) |
| IS (1) | IS8697A (fr) |
| IT (1) | ITRM20070650A1 (fr) |
| MA (1) | MA30998B1 (fr) |
| TN (1) | TN2009000219A1 (fr) |
| WO (1) | WO2008074936A1 (fr) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015011307A1 (fr) * | 2013-07-26 | 2015-01-29 | Universidad De Cádiz (Otri) | Produit alimentaire bénéfique pour la santé |
| WO2019053677A1 (fr) * | 2017-09-15 | 2019-03-21 | Olitalia S.R.L. | Composition d'huile comestible, destinée en particulier à être utilisée pour frire et cuire des aliments |
| IT201700112718A1 (it) * | 2017-10-06 | 2019-04-06 | Olitalia S R L | Composizione di olio alimentare, particolarmente per l'uso nella frittura e cottura di alimenti |
| US11278037B2 (en) | 2017-09-22 | 2022-03-22 | Conopco Inc. | Composition comprising vegetable oil and apple cider vinegar |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011071365A1 (fr) | 2009-12-07 | 2011-06-16 | N.V. Nutricia | Composition lipidique équilibrée et son utilisation dans une composition nutritionnelle liquide adaptée à l'alimentation entérale |
| US10682327B2 (en) * | 2011-04-17 | 2020-06-16 | Omega Foods, LLC | Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids |
| US10653160B2 (en) * | 2011-04-17 | 2020-05-19 | Omega Foods, LLC | Prepared foods having high efficacy omega 6/omega 3 balanced polyunsaturated fatty acids |
| US20210176999A1 (en) | 2011-04-17 | 2021-06-17 | Omega Foods, LLC | Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids |
| CN104255950A (zh) * | 2014-09-19 | 2015-01-07 | 广东润科生物工程有限公司 | 一种含有dha的菜籽调和油及其制备方法 |
| JP2018115282A (ja) * | 2017-01-20 | 2018-07-26 | 日清オイリオグループ株式会社 | 柑橘系香料の香り立ち増強剤と改良香料 |
| ES2926841T3 (es) * | 2019-04-12 | 2022-10-28 | Unilever Ip Holdings B V | Composición alimenticia emulsionada de aceite en agua con aceite alto oleico |
| IT202300003186A1 (it) * | 2023-02-23 | 2024-08-23 | Oleificio Zucchi S P A | Composizione di olio edibile per la frittura di prodotti alimentari |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69326949T2 (de) * | 1993-08-20 | 2000-02-17 | Societe Des Produits Nestle S.A., Vevey | Lipidzusammensetzung für Nahrungsmittel |
| LT4734B (lt) * | 2000-01-21 | 2000-11-27 | Alfridas Putramentas | Aliejų kompozicija |
| FR2878413B1 (fr) * | 2004-11-26 | 2007-01-26 | Lesieur S A S | Composition lipidique presentant des proprietes nutritionnelles et organoleptiques d'interet |
-
2006
- 2006-12-19 FR FR0611077A patent/FR2909839B1/fr not_active Expired - Fee Related
-
2007
- 2007-11-13 EP EP07870279.2A patent/EP2101594B1/fr active Active
- 2007-11-13 WO PCT/FR2007/001870 patent/WO2008074936A1/fr not_active Ceased
- 2007-12-04 IS IS8697A patent/IS8697A/is unknown
- 2007-12-17 IT IT000650A patent/ITRM20070650A1/it unknown
- 2007-12-18 BE BE2007/0606A patent/BE1019597A5/fr active
-
2009
- 2009-05-29 TN TNP2009000219A patent/TN2009000219A1/fr unknown
- 2009-06-16 MA MA31998A patent/MA30998B1/fr unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015011307A1 (fr) * | 2013-07-26 | 2015-01-29 | Universidad De Cádiz (Otri) | Produit alimentaire bénéfique pour la santé |
| ES2539844A1 (es) * | 2013-07-26 | 2015-07-06 | Universidad De Cádiz | Producto alimenticio saludable |
| WO2019053677A1 (fr) * | 2017-09-15 | 2019-03-21 | Olitalia S.R.L. | Composition d'huile comestible, destinée en particulier à être utilisée pour frire et cuire des aliments |
| US11278037B2 (en) | 2017-09-22 | 2022-03-22 | Conopco Inc. | Composition comprising vegetable oil and apple cider vinegar |
| US11910804B2 (en) | 2017-09-22 | 2024-02-27 | Conopco Inc. | Composition comprising vegetable oil and apple cider vinegar |
| IT201700112718A1 (it) * | 2017-10-06 | 2019-04-06 | Olitalia S R L | Composizione di olio alimentare, particolarmente per l'uso nella frittura e cottura di alimenti |
Also Published As
| Publication number | Publication date |
|---|---|
| MA30998B1 (fr) | 2009-12-01 |
| FR2909839B1 (fr) | 2009-06-19 |
| BE1019597A5 (fr) | 2012-09-04 |
| ITRM20070650A1 (it) | 2008-06-20 |
| EP2101594B1 (fr) | 2014-03-19 |
| IS8697A (is) | 2008-06-20 |
| FR2909839A1 (fr) | 2008-06-20 |
| WO2008074936A1 (fr) | 2008-06-26 |
| TN2009000219A1 (fr) | 2010-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1019597A5 (fr) | Composition lipidique presentant des proprietes d'interet. | |
| KR101481197B1 (ko) | 토코페롤 및 토코트리에놀을 함유하는 조성물의 제조방법 | |
| US20080193605A1 (en) | Nutritionally enhanced nut product | |
| RU2580470C2 (ru) | Пищевые эмульсии | |
| EP0937408A2 (fr) | Aliment contenant une composition lipidique nutritionnelle | |
| AU3598599A (en) | Fortification of a vegetable fat with antioxidants | |
| JP7498236B2 (ja) | 容器詰食用油及びその製造方法 | |
| DK2366766T3 (en) | Process for treating an edible oil and thus obtained oil | |
| TW201002215A (en) | Taste-improving agent for foods and drinks | |
| JP6689042B2 (ja) | 酸性水中油型乳化食品 | |
| CN102469820A (zh) | 富含ω-3的坚果黄油及其相关产物 | |
| EP1280420B9 (fr) | Huile vegetale naturelle concentree en insaponifiable comme ingredient alimentaire | |
| EP2285242B1 (fr) | Combinaisons d'extrait vegetal et d'acides gras polyinsatures | |
| BE1016861A3 (fr) | Composition lipidique presentant des proprietes nutritionelles et organoleptiques d'interet. | |
| EP0630189B1 (fr) | Sauce alimentaire de type mayonnaise, procede de preparation d'une telle sauce et preparation alimentaire la contenant | |
| EP1515613A1 (fr) | Corps gras vegetal et son utilisation dans des preparations alimentaires | |
| CN102639015B (zh) | 汁液或汁液饮料制品 | |
| Combe et al. | Huiles végétales et friture | |
| WO2001026486A1 (fr) | Composition alimentaire ou dietetique contenant plusieurs antioxydants | |
| EP4681547A1 (fr) | Procede d obtention d'une emulsion eau-dans-huile a base d huile vegetale et de stearine de beurre | |
| FR2745979A1 (fr) | Additif alimentaire pour animaux | |
| JP2018050567A (ja) | ヒドロキシチロソールと魚油を含有する食品組成物 | |
| FR2943506A1 (fr) | Composition alimentaire allegee en matiere grasse, pauvre en sel, riche en omega-3 et enrichie en phytosterols | |
| EP3446571A1 (fr) | Assaisonnement émulsifié | |
| FR3148036A1 (fr) | Composition d’huile enrichie en acides gras polyinsaturés |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20090310 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20100219 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A23L 1/24 20060101ALI20130911BHEP Ipc: A23D 9/02 20060101ALI20130911BHEP Ipc: A23L 1/39 20060101ALI20130911BHEP Ipc: A23L 1/303 20060101ALI20130911BHEP Ipc: A23L 1/302 20060101ALI20130911BHEP Ipc: A23D 9/00 20060101AFI20130911BHEP Ipc: A23L 1/30 20060101ALI20130911BHEP |
|
| INTG | Intention to grant announced |
Effective date: 20131001 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 657042 Country of ref document: AT Kind code of ref document: T Effective date: 20140415 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602007035707 Country of ref document: DE Effective date: 20140430 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20140319 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 657042 Country of ref document: AT Kind code of ref document: T Effective date: 20140319 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140619 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602007035707 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140721 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 |
|
| 26N | No opposition filed |
Effective date: 20141222 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602007035707 Country of ref document: DE Effective date: 20141222 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602007035707 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141113 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20141113 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141130 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141130 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141113 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141113 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150602 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140620 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140319 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20071113 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20171127 Year of fee payment: 11 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181113 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IS Payment date: 20251111 Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20251125 Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20251127 Year of fee payment: 19 |